Aspira Pathlab & Diagnostics Limited (BOM:540788)
60.55
-0.77 (-1.26%)
At close: Feb 13, 2026
BOM:540788 Market Cap
BOM:540788 has a market cap or net worth of 623.24 million as of February 13, 2026. Its market cap has decreased by -23.63% in one year.
Market Cap
623.24M
Enterprise Value
635.21M
Revenue
242.36M
Ranking
n/a
PE Ratio
74.84
Stock Price
60.55
Market Cap Chart
Since February 28, 2018, BOM:540788's market cap has increased from 31.84M to 623.24M, an increase of 1,857.57%. That is a compound annual growth rate of 45.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 623.24M | -8.51% |
| Dec 31, 2025 | 681.19M | 11.23% |
| Dec 31, 2024 | 612.43M | 51.86% |
| Dec 22, 2023 | 403.28M | -8.99% |
| Dec 30, 2022 | 443.11M | -44.20% |
| Dec 31, 2021 | 794.10M | 219.45% |
| Dec 24, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thyrocare Technologies | 63.92B |
| One Global Service Provider | 14.06B |
| Chandan Healthcare | 7.25B |
| Star Imaging and Path Lab | 1.38B |
| Modern Diagnostic & Research Centre | 1.20B |
| Invicta Diagnostic | 867.47M |
| Nidan Laboratories and Healthcare | 248.81M |
| Family Care Hospitals | 191.75M |